Clinical Trial Update: Observational Program to Assess Use of Intermittent Adjuvant Deprivation Therapy With Leuprorelin (Lucrin Depot) in Patients With Advanced Prostate Cancer (PCa) in Russia

View source ↗

Summary

This completed observational program evaluated intermittent adjuvant deprivation therapy with Leuprorelin (Lucrin Depot) in advanced prostate cancer patients in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Lucrin Depot (Leuprorelin)

Snippet

Sponsor: AbbVie (prior sponsor, Abbott) | Conditions: Prostate Cancer | Status: COMPLETED | Results posted: 2015-07-08